Clinical trial · Observational
The Chinese Pulmonary Lymphoepithelioma-like Carcinoma Collaboration Study
Genetic Susceptibility Study of Primary Pulmonary Lymphoepithelioma-like Carcinoma
NCT06801977CI-TRIAL-00085305CPLCCrecruitingClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This retrospective case-control study aims to investigate the genetic mechanisms of primary Pulmonary Lymphoepithelioma-like Carcinoma, identify genetic susceptibility loci associated with its onset, and explore potential pathogenic genes, providing new insights for its etiological research.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Primary Pulmonary Lymphoepithelioma-like Carcinoma | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Genome-wide genotyping | Genetic | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- label
- SYSUCC cohort, Guangdong, China
- description
- Cases: Patients aged 18 and above with a pathological diagnosis of primary pulmonary lymphoepithelioma-like carcinoma who were treated at the Sun Yat-sen University Cancer Center from January 1, 2002. Controls: Healthy participants aged 18 and above.
- interventionNames
- Genetic: Genome-wide genotyping
- label
- Foshan cohort, Guangdong, China
- description
- Cases: Patients aged 18 and above with a pathological diagnosis of primary pulmonary lymphoepithelioma-like carcinoma who were treated at the the First People's Hospital of Foshan from January 1, 2007. Controls: Healthy participants aged 18 and above.
- interventionNames
- Genetic: Genome-wide genotyping
Primary outcomes (1)
- measure
- the occurrence of Pulmonary Lymphoepithelioma-like Carcinoma
- timeFrame
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Case: Inclusion criteria: The subject is pathologically diagnosed with primary pulmonary lymphoepithelioma-like carcinoma. Exclusion criteria: The subject is diagnosed with metastatic nasopharyngeal carcinoma; The subject has heavy cardiovascular, liver, or kidney disease. Controls: Inclusion criteria: The subject is in good physical condition and has a stable level of consciousness; Exclusion criteria: The subject has prevalent cancer; The subject has heavy cardiovascular, liver, or kidney disease.
References
Publications (0)
Data not yet available
No reference posted for this study.